There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

Other unsolved mathematical mysteries are akin to the branches of trees. The trees themselves—fields within the wider subject ...

Assignment of square colors to the CS (CS+ and CS− ... For study 3, for the reminder groups (reminder-dlPFC and reminder-vertex groups), only one of the CS+ (CS1+) was presented once (without the US ...

People surrounded a police car and raised slogans. Indore witnessed high drama on Saturday as lawyers staged a three-hour-long protest, blocking the High Court square. Videos from the scene ...

Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.

Block's Q4 results missed expectations, despite double-digit growth in Cash App and Square, especially in the Cash App segment. Block's robust earnings report highlights impressive gross profit ...

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

The Block Thesis: While market sentiment is now "more balanced," there is less downside risk to Street estimates, Hone said in the upgrade note. Check out other analyst stock ratings. Square ...

Police said officers responded to the Homan Square neighborhood's 3500-block of West Polk Street just before 6 p.m. A 25-year-old man and a female victim, whose age was not immediately known ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...